{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Possibly Marketed Outside US
Source:
Tendera-OB by BonGeo Pharmaceuticals, Inc.
(2019)
Source URL:
First approved in 2011
Source:
21 CFR 348
Source URL:
Class:
CONCEPT
Status:
Possibly Marketed Outside US
Source:
21 CFR 333E
(2020)
Source URL:
First approved in 2009
Source:
21 CFR 358H
Source URL:
Class:
CONCEPT
Status:
Possibly Marketed Outside US
Source:
21 CFR 333E
(2009)
Source URL:
First approved in 2009
Source:
21 CFR 333E
Source URL:
Class:
CONCEPT
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2019)
Source URL:
First approved in 2007
Source:
21 CFR 352
Source URL:
Class:
CONCEPT
Status:
Possibly Marketed Outside US
Source:
21 CFR 347
(2013)
Source URL:
First approved in 2007
Source:
21 CFR 352
Source URL:
Class:
CONCEPT
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2021)
Source URL:
First approved in 2007
Source:
21 CFR 358H
Source URL:
Class:
CONCEPT
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2007)
Source URL:
First approved in 2007
Source:
21 CFR 352
Source URL:
Class:
CONCEPT
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2016)
Source URL:
First approved in 2006
Source:
21 CFR 352
Source URL:
Class:
CONCEPT
Status:
Possibly Marketed Outside US
Source:
BLA125350
(2010)
Source URL:
First approved in 2004
Source:
BLA125070
Source URL:
Class:
CONCEPT
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(2021)
Source URL:
First approved in 2000
Source:
ANDA205622
Source URL:
Class:
CONCEPT